Skip to main content
INDV logo

INDV · Indivior Pharmaceuticals, Inc. · Analyst Estimates

Track INDV — free
$36.00 +0.15 (+0.42%)
Market Cap
$4.23B
Shares
118.01M
Volume · Sep 30 1.67M Avg daily vol (3M) 2.03M

Analyst Estimates

Compare analyst forecasts for Indivior Pharmaceuticals, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 15:06 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
4.36
4.40867
4.47
—
3.8248
3.8525
4.47
3.8525
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
3
0
Revenue
USD
Publication date not stated
1318100000
1331966670
1341500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
4.74
4.88333
5.02
—
4.1422
3.92
4.337
3.92
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
3
2
Revenue
USD
Publication date not stated
1373800000
1399533330
1413500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.088
1.119
1.15
—
0.97075
0.99
0.98075
0.99
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
2
2
Revenue
USD
Publication date not stated
326700000
329350000
332000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.209
1.2145
1.22
—
1.0425
1.06333
1.055
1.06333
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
2
2
Revenue
USD
Publication date not stated
331500000
337900000
344300000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —
Key facts CIK 1625297 CUSIP 45579U109 13F (30d) 8 filings 8 filers Visit website Investor relations